Author: Roz Bekker, managing director UK & Ireland, Johnson & Johnson Innovative Medicine

Without doubt, when we reflect on the many achievements of the UK healthcare system and our NHS, there is much to be proud of – but today we are faced with a paradox. We are living in a time where breakthrough science has the potential to transform treatment options for some of the toughest health conditions faced by patients in the UK. Yet the question is whether the system is currently set up to match the pace of innovation that science provides, so patients can fully benefit? At Johnson & Johnson, our teams are continuously working to get ahead of…

Read More